Get Your Personalized Supplement StackSupplement Stack Quiz

NTFactor Proprietary Lipid Blend

Also known as: NTFactor Lipids®, Membrane Lipid Replacement (MLR) lipid supplement, NTFactor Proprietary Lipid Blend

Overview

NTFactor Proprietary Lipid Blend, also known as NTFactor Lipids®, is a nutritional supplement classified as a membrane lipid replacement therapy (MLR) agent. It is a complex mixture of membrane glycerolphospholipids, primarily composed of phosphatidylcholine, phosphatidylinositol, phosphatidylethanolamine, and phosphatidic acid, enriched with unsaturated fatty acids like linoleic and palmitic acid. This blend is designed to mimic the natural lipid composition of mitochondrial membranes. Its primary function is to replace damaged membrane lipids within mitochondria and other cellular membranes, thereby restoring their integrity and function. NTFactor is used to improve mitochondrial function, reduce fatigue, enhance the bioavailability of poorly absorbed nutrients (such as CoQ10, curcumin, and quercetin), and alleviate symptoms associated with chronic illnesses and chemical exposures. The research on NTFactor is moderate, with several clinical and in vitro studies supporting its uses, though high-quality randomized controlled trials are still limited.

Benefits

NTFactor Proprietary Lipid Blend offers several evidence-based benefits, primarily centered on cellular membrane health and energy production. It significantly enhances the bioavailability of poorly absorbed nutrients, with in vitro studies showing a two-fold increase in CoQ10 absorption (p=0.0011). This suggests improved nutrient uptake, which is crucial for overall cellular function. Clinically, NTFactor has demonstrated a reduction in fatigue severity and an improvement in mitochondrial function, particularly in individuals with chronic fatigue syndrome and those exposed to chemicals. Open-label studies involving chemically exposed Gulf War veterans and patients with moderate to severe chronic fatigue have shown gradual but significant reductions in various symptoms, including pain, musculoskeletal issues, sleep disturbances, and chemical sensitivities, over periods ranging from weeks to six months. While these clinical findings are promising, they largely stem from open-label studies, indicating a need for more rigorous randomized controlled trials to confirm effect sizes and clinical significance.

How it works

NTFactor Proprietary Lipid Blend functions primarily by replacing damaged glycerolphospholipids in cellular and mitochondrial membranes. This process, known as Membrane Lipid Replacement (MLR), restores the integrity and fluidity of these membranes, which are crucial for optimal cellular function. By repairing and protecting membranes from oxidative damage, NTFactor supports efficient mitochondrial energy production (ATP synthesis). It also enhances nutrient absorption, particularly for poorly bioavailable compounds, by improving membrane transport mechanisms in the gastrointestinal tract. The blend's specific lipid composition allows it to integrate into existing membranes, thereby improving cellular energy metabolism and reducing oxidative stress.

Side effects

Based on available research, NTFactor Proprietary Lipid Blend is generally considered safe, with no major adverse events reported in clinical trials or open-label studies. Common side effects are not well-documented, and no significant side effects have been reported in the reviewed studies. Information regarding uncommon or rare side effects is currently unavailable from high-quality studies. Drug interactions have not been extensively studied, so caution is advised when co-administering NTFactor with other medications or supplements due to the lack of comprehensive interaction data. There are no specific contraindications reported. While studies have included chemically exposed veterans and chronic fatigue patients, the safety of NTFactor in special populations such as pregnant women, children, or individuals with severe comorbidities has not been established.

Dosage

Clinical studies have typically utilized an oral dosage of approximately 6 grams per day of NTFactor Lipids. This dosage appears to be effective in achieving symptom reduction over several months, particularly for fatigue and other chronic symptoms. There are currently no dose-ranging randomized controlled trials available to precisely define optimal dosage ranges or a minimum effective dose. The maximum safe dose for NTFactor has not been established due to limited comprehensive safety data. Benefits are observed with continuous daily use over weeks to months, suggesting that consistent intake is important for efficacy. NTFactor is an oral lipid supplement, and its bioavailability, as well as that of co-administered nutrients like CoQ10, curcumin, and quercetin, is enhanced when taken together. It is often studied in combination with antioxidants for potential synergistic effects.

FAQs

Is NTFactor safe?

Available evidence suggests NTFactor is generally safe, with no major adverse effects reported in clinical studies. However, safety in specific populations like pregnant women or children is not established.

How long until benefits appear?

Improvements in mitochondrial function and fatigue may be observed within 4-8 weeks, with more significant symptom reductions continuing over 6 months of consistent use.

Can it be taken with other supplements?

Yes, NTFactor can enhance the absorption of certain nutrients like CoQ10, curcumin, and quercetin. However, specific interactions with all supplements are not well-studied.

Is it effective for all fatigue types?

Evidence is strongest for chronic fatigue syndrome and chemically induced fatigue. Its effectiveness for other types of fatigue is not yet clear and requires further research.

Research Sources

https://ffhdj.com/index.php/BioactiveCompounds/article/view/936/4290 – This in vitro study used a Caco-2 cell model to demonstrate that NTFactor significantly increased the absorption of poorly bioavailable nutrients like CoQ10 (2-fold), curcumin, and quercetin. The findings suggest NTFactor's role in enhancing nutrient bioavailability at a cellular level, with statistically significant results for CoQ10 absorption (p=0.0011).
https://ntfactor.com/wp-content/uploads/2022/09/61Nicolson-et-al-Membrane-lipid-Replacement-with-Nt-Factor-Lipids-Enhancement-of-Nutrient-Biovailability-and-Reductions-in-Symptom-Severities-in-Chemically-exposed-Veterans-.pdf – This open-label clinical study involving chemically exposed veterans showed significant reductions in multiple symptom severities over 6 months with a daily 6g dose of NTFactor. While promising, the study's open-label design and reliance on self-reported symptoms are limitations, indicating a need for controlled trials.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6941554/ – This review article provides an overview of NTFactor's lipid composition, proposed mechanism of action, and summarizes preliminary clinical benefits observed in fatigue. It highlights the role of membrane lipid replacement in restoring cellular function but notes the lack of extensive high-level randomized controlled trial evidence.
https://ntfactor.com/wp-content/uploads/2022/06/16-Nicolson-Ellithorpe-Lipid-replacement-and-antioxidantnutritional-therapy-for-restoring-mitochondrial-functionand-reducing-fatigue-ib-chronic-fatigue-syndrome-and-other-Fatiguing-illnesses.pdf – This clinical study investigated the effects of NTFactor combined with antioxidants on chronic fatigue. It reported significant reductions in fatigue and improvements in mitochondrial function within 4-8 weeks in patients with moderate-to-severe fatigue. The study's findings are promising but are limited by a small sample size and the absence of a placebo control group.